Gartner® Market Guide 2023 for Augmented Analytics Focuses on the Impact of Generative AI and Domain-Specificity

A New Era of Personalization: Applying Generative AI to Dynamic Customer Engagement

View now

Webinar Series: Part 4 - Give Your Life Sciences Analytics the ExplAIn Advantage

View now

Customer Centricity and Digital Experiences which are Redefining Pharma

It is no secret that the pharmaceutical industry has historically flourished from blockbuster products with substantial brand equity, favorable pricing

View now

Adding Up Data Analytics Total Cost of Ownership (TCO) and How to Lower It

High data analytics expenditures don’t have to be a cost of doing business for life sciences companies. WhizAI lowers the total cost of ownership (TCO) while making data insights more accessible to business users. Traditionally, data analytics TCO has been a significant expense for life sciences organizations.

Download now

Transforming Life Sciences Commercial Function with AI and Augmented Analytics

In this whitepaper, sponsored by WhizAl, Everest Group explores the business case and profound impact Al and Augmented Analytics can have on the life sciences commercial function across various use cases in Sales, Marketing, and Market Access. They examine what top pharma enterprises are looking for in an augmented analytics tool, a roadmap for how to get started, and a blueprint for adoption.

Download now

Augmented Analytics is “On the Rise” on Gartner’s 2022 Hype Cycle for Life Science Commercial Operations

The Gartner​® 2022 Hype Cycle™ for Life Science Commercial Operations introduces a new category, Augmented Analytics, this year. WhizAI is listed as a sample vendor in the Augmented Analytics category in this Hype Cycle. This summary report covers the following highlights.

Download now

The GenAI Revolution: Insights from Industry Leaders on Transforming Pharma Commercial Analytics

The pharma and life sciences industry is undergoing a seismic shift, with GenAI emerging as a game-changer for analytics and decision-making. This was the central theme of our recent webinar hosted by WhizAI and the Pharmaceutical Management Science Association (PMSA), featuring an expert panel of industry leaders on the topic ‘Conversations with Industry Leaders at the Forefront of GenAI in Pharma Commercial Analytics’.

Read more

From Hype to Reality: How LLMs are Transforming Data Insights in Life Sciences

Discover how Large Language Models (LLMs) are reshaping data insights in life sciences. Learn about WhizAI's tailored approach to overcoming industry challenges and delivering real-world impact through domain-specific precision and empowered decision-making.

Read more

Data That Speaks Your Language, Instantly: Why WhizAI Outperforms Traditional LLMs in Life Sciences Analytics

WhizAI has been a generative AI platform from its inception in 2018, even before LLMs became mainstream. Our proprietary NLP engine combines deep learning with linguistic techniques, allowing users to ask questions conversationally and receive accurate, contextual responses in less than a second.

Read more